Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Protara Therapeutics Inc., 3 years.
Protara Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 16, 2025 | Incyte Corp. | Open-market sale | −1,340 | $68.36 | $91,602 |
| Jul 15, 2025 | Incyte Corp. | Open-market sale | −1,192 | $69.86 | $83,273 |
| Jul 15, 2025 | Incyte Corp. | Shares withheld for tax | −1,141 | $68.25 | $77,873 |
| Jul 14, 2025 | Incyte Corp. | Shares withheld for tax | −922 | $69.98 | $64,522 |
| Jul 3, 2025 | Incyte Corp. | Open-market sale | −10,903 | $68.15 | $743,039 |
| Jul 2, 2025 | Incyte Corp. | Shares withheld for tax | −9,055 | $68.17 | $617,279 |
| Apr 1, 2025 | Incyte Corp. | Grant or award | +11,159 | — | — |
| Apr 1, 2025 | Incyte Corp. | Grant or award | +14,976 | — | — |
| Mar 14, 2025 | Incyte Corp. | Open-market sale | −461 | $67.85 | $31,279 |
| Mar 14, 2025 | Incyte Corp. | Open-market sale | −199 | $67.88 | $13,508 |
| Mar 14, 2025 | Incyte Corp. | Open-market sale | −19,147 | $67.68 | $1,295,869 |
| Jan 15, 2025 | Incyte Corp. | Shares withheld for tax | −3,158 | $72.46 | $228,829 |
| Dec 9, 2024 | Incyte Corp. | Shares withheld for tax | −1,510 | $72.11 | $108,886 |
| Nov 6, 2024 | Incyte Corp. | Option exercise | +1,424 | $72.27 | $102,912 |
| Nov 6, 2024 | Incyte Corp. | Option exercise | +2,256 | $68.62 | $154,807 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.